The generic name of the cardioplegia drug is propafenone hydrochloride tablets, which can be discontinued after 15 years of consumption, propafenone hydrochloride tablets do not belong to the long-term application of the drug, but only for a short period of time after the appearance of an abnormal health condition.
Propafenone hydrochloride tablets are mainly used for supraventricular tachycardia, including atrioventricular junctional tachycardia, preexcitation syndrome with supraventricular tachycardia or atrial fibrillation, or pathogenic ventricular tachycardia that needs to be treated as judged by the physician, the corresponding drug can be discontinued after 15 years of application, which needs to be dealt with under the guidance of the clinician.
Adverse effects of Propafenone Hydrochloride Tablets are dizziness, headache, syncope, cardiac conduction abnormalities, palpitations (rapid heartbeat, often accompanied by panic), arrhythmia, thrombocytopenia, anxiety, dyspnea, abdominal pain, diarrhea, and rash.
Contraindications to propafenone hydrochloride tablets are patients suffering from brugada syndrome, heart failure, cardiogenic shock, severe bradycardia, cardiac compromise, severe conduction block, severe morbid sinus node syndrome, severe hypotension, significant electrolyte disorders are contraindicated, and those who are allergic to the product are contraindicated.
Once obvious headache, gastrointestinal reactions and generalized multiple skin rashes occur during the use of the drug, the drug should be promptly discontinued for medical observation.